MedTrace Logo

Screening to Predict Weight Loss in Patients With Cancer

NCT00710632 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 220

Last updated 2013-09-17

No results posted yet for this study

Summary

RATIONALE: Screening tests may identify people with cancer who are at high risk of losing weight and help doctors plan better treatment.

PURPOSE: This clinical trial is studying how well a new screening tool works in predicting weight loss in patients with cancer.

Conditions

Interventions

OTHER

laboratory biomarker analysis

OTHER

physiologic testing

OTHER

questionnaire administration

PROCEDURE

management of therapy complications

Sponsors & Collaborators

  • Queen's Medical Center

    lead OTHER

Principal Investigators

  • Vanessa Halliday, MSC · University of Nottingham

Study Design

Purpose
SUPPORTIVE_CARE

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-09-30
Primary Completion
2008-08-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00710632 on ClinicalTrials.gov